Christian Guilleminault

Publication Details

• Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride.

  Guilleminault C, Raynal D, Takahashi S, Carskadon M, Dement W. Acta Neurol Scand. 1976; 54 (1): 71-87

  Clinical examinations, questionnaires, and 24- or 36-hour polygraphic recordings were performed on 21 adult patients with the narcolepsy syndrome to investigate the short- and long-term effects of clomipramine HCL. Cataplexy was improved by the medication, but tolerance was observed 4 1/2 months of treatment. Clomipramine HCL induced significant changes in the sleep EEG, chin EMG, and EOG. In two patients, clomipramine HCL caused a nocturnal myoclonia that produced insomnia. Sexual side effects were seen with clomipramine HCL, particularly in males. A combination of clomipramine HCL and L-Dopa apparently prevented this difficulty in one patient. A rebound of cataplexy was seen during the 15 days following withdrawal of the drug. Methysergide maleate was found to be ineffective on cataplexy in four patients.

  PubMedID: 936975